Novavax Inc. Common Stock (NVAX)

Fundamentals

Market cap

$1.27B

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

—

Dividend yield

—

Beta

—

Avg. volume

—

Novavax Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• NVAX

  Novavax Inc. Common Stock

  $9.27

  ▲ 2.43%
  Market cap $1.27BP/E —
• IMTX

  Immatics N.V. Ordinary Shares

  $9.45

  ▲ 0.91%
  Market cap $1.26BP/E —
  $5.05$12.41
• VOR

  Vor Biopharma Inc. Common Stock

  $22.66

  ▼ 3.70%
  Market cap $1.28BP/E —
  $6.5$49.95
• INBX

  Inhibrx Biosciences Inc. Common Stock

  $123.93

  ▼ 0.00%
  Market cap $1.26BP/E —
  $26.19$155.29
• GLUE

  Monte Rosa Therapeutics Inc. Common Stock

  $13.37

  ▼ 6.63%
  Market cap $1.33BP/E —
  $4.6$25.77
• MGTX

  MeiraGTx Holdings plc Ordinary Shares

  $13.8

  ▼ 2.40%
  Market cap $1.18BP/E 15.54
  $6.62$15.35
• VIR

  Vir Biotechnology Inc. Common Stock

  $10.83

  ▼ 4.24%
  Market cap $1.48BP/E —

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• QUICK SPARK: FDA Approves Updated COVID Vaccines From Moderna, Pfizer, Novavax
  benzinga · 8/27/2026
• Recursion, Novavax and Crispr Stocks Trending in Pre-Market—Here's Why
  Benzinga · 8/20/2026
• Novavax Stock Moves Higher Wednesday: What's Driving the Action?
  Benzinga · 8/19/2026
• Trump Says Administration Recognizing Childhood Vaccine Recommendations For Only 11 Core Vaccinations; Hepatitis B, COVID-19, Influenza No Longer Recommended For All Children
  Benzinga · 8/10/2026
• Novavax (NVAX) Is Up 8.6% After Beating Q2 Estimates And Expanding Big-Pharma Partnerships - What's Changed
  Yahoo · 8/8/2026
• NVAX Q2 Earnings & Sales Beat Estimates, '26 Sales Outlook Raised
  Yahoo · 8/7/2026
• Novavax Q2 Earnings Call Highlights
  Yahoo · 8/7/2026
• Novavax Inc (NVAX) (Q2 2026) Earnings Call Highlights: Matrix-M Momentum Drives Revenue ...
  Yahoo · 8/6/2026
• NVAX Stock Holds Steady As Novavax Lifts Revenue Outlook On Licensing Pivot — Retail Eyes Buyout, More Partnership Deals
  Yahoo · 8/6/2026

• Richard J. Rodgers · June 20, 2026 · Option Exercise

  18.9K
• King Rachel K. · June 20, 2026 · Option Exercise

  18.9K
• Richard Douglas · June 20, 2026 · Option Exercise

  18.9K
• MCGLYNN MARGARET G · June 20, 2026 · Option Exercise

  18.9K
• MOTT DAVID M · June 20, 2026 · Option Exercise

  18.9K
• Alton Gregg H · June 20, 2026 · Option Exercise

  18.9K
• Richard J. Rodgers · June 18, 2026 · Grant

  14.2K
• Richard J. Rodgers · June 18, 2026 · Grant

  21.3K
• King Rachel K. · June 18, 2026 · Grant

  14.2K
• King Rachel K. · June 18, 2026 · Grant

  21.3K
• Richard Douglas · June 18, 2026 · Grant

  14.2K
• Richard Douglas · June 18, 2026 · Grant

  21.3K
• MCGLYNN MARGARET G · June 18, 2026 · Grant

  14.2K
• MCGLYNN MARGARET G · June 18, 2026 · Grant

  21.3K
• MOTT DAVID M · June 18, 2026 · Grant

  14.2K

Institutional Ownership

March 31, 2026

Total shares held

118.48M

Total value held

$958.47M

Institutional holders

253